MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cerus Corp. Company Profile (NASDAQ:CERS)

Consensus Ratings for Cerus Corp. (NASDAQ:CERS) (?)
Ratings Breakdown: 1 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $8.70 (38.76% upside)

Analysts' Ratings History for Cerus Corp. (NASDAQ:CERS)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016Robert W. BairdReiterated RatingOutperform$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016BTIG ResearchReiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2016FBR & CoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016Cantor FitzgeraldReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2016StephensReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2015WedbushDowngradeOutperform -> Neutral$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2015MLV & Co.Reiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Cerus Corp. (NASDAQ:CERS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/3/2016Q1($0.16)($0.17)$8.29 million$7.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415($0.16)($0.15)$9.72 million$9.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.16)($0.17)$10.00 million$8.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.15)($0.17)$8.71 million$8.83 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q214($0.16)($0.17)$7.70 million$7.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q114($0.15)($0.25)$10.36 million$9.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q413($0.13)($0.15)$9.83 million$10.36 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q313($0.13)($0.16)$8.17 million$8.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q313($0.12)($0.12)$9.65 million$7.86 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2014Q213($0.09)($0.10)$11.77 million$9.23 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013($0.09)($0.29)$10.34 million$10.54 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Cerus Corp. (NASDAQ:CERS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.17)($0.17)($0.17)
Q2 20161($0.16)($0.16)($0.16)
Q3 20161($0.16)($0.16)($0.16)
Q4 20161($0.16)($0.16)($0.16)
(Data provided by Zacks Investment Research)
Dividend History for Cerus Corp. (NASDAQ:CERS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Cerus Corp. (NASDAQ:CERS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
8/19/2015Laurence M CorashInsiderBuy25,900$4.99$129,241.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Laurence M CorashInsiderBuy84,600$4.77$403,542.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014William Mariner GreenmanCEOBuy21,800$3.93$85,674.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2012William Mariner GreenmanCEOBuy3,200$3.02$9,664.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2012Laurence M CorashInsiderBuy2,000$2.85$5,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2012William Mariner GreenmanCEOBuy13,800$2.85$39,330.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Cerus Corp. (NASDAQ:CERS)
DateHeadline
07/01/16 03:11 PMAnalyst Recommended Stock: Cerus Corporation (NASDAQ:CERS) - News Oracle
07/01/16 03:11 PMCerus Corporation (NASDAQ:CERS) Receives $2 Million For Blood Safety Program For Africa - Market Exclusive
07/01/16 03:11 PMCerus Corporation (CERS) Current Analyst Ratings - Fiscal Standard
07/01/16 11:12 AMCerus Corporation (NASDAQ:CERS) Receives $2 Million For Blood Safety Program For Africa
06/30/16 07:32 AM8:32 am Cerus receives a grant of CHF 2 mln from the Swiss Red Cross Humanitarian Foundation -
06/30/16 07:30 AMCerus Corporation, the Transfusion Service of the Swiss Red Cross, and the University Hospital of Basel Receive a Grant of 2 Million Swiss Francs From the Swiss Red Cross Humanitarian Foundation for Whole Blood Pathogen Inactivation for Afr - [Business Wire] - Cerus Corporation , announced today that the Swiss Red Cross Humanitarian Foundation has awarded a grant of 2 million Swiss Francs to Cerus, the University Hospital of Basel, and the Swiss Transfusion SRC to complete the necessary clinical studies to develop a whole blood pathogen inactivation system for use in Africa.
06/29/16 08:13 PMWill Senate Recess Without Approving Zika Funding Amid Mosquito Season? - Benzinga
06/29/16 08:13 PMCerus Corporation Stock Momentum Hits Strength - CML News
06/27/16 03:04 PMWhy Investors Have These Biotech Stocks on Their Radar? - Cerus, Juno Therapeutics, Chiasma, and Sage Therapeutics
06/27/16 07:45 AMWhy Investors Have These Biotech Stocks on Their Radar? - Cerus, Juno Therapeutics, Chiasma, and Sage ... - PR Newswire (press release)
06/26/16 08:18 AMCerus Corporation (NASDAQ:CERS) Shorted Shares Increased By 6.32% - Engelwood Daily
06/23/16 10:55 AMRecently Issued Stock Ratings For Cerus Corporation (CERS) - Fiscal Standard
06/23/16 10:55 AMCerus Corporation (CERS) Updated Price Targets - FTSE News
06/22/16 03:18 PMCerus Corporation (CERS) Jumps 7.72% on June 20 - Equities.com
06/22/16 03:18 PMBaird Bullish on EXACT Sciences Corporation (EXAS) and Cerus Corporation (CERS); Here's Why - Smarter Analyst
06/21/16 03:01 PMUS to help fund technology to eliminate Zika in blood supply
06/21/16 03:01 PMAnalyst’s Review to Watch: Cerus Corporation (NASDAQ:CERS)
06/21/16 10:23 AMCerus Corp. – Value Analysis (NASDAQ:CERS) : June 21, 2016 -
06/21/16 07:54 AMHC Trending Hot Stocks: Cerus Corporation (NASDAQ:CERS), Hologic, Inc. (NASDAQ:HOLX) - share market updates (press release)
06/21/16 07:54 AM5 Health Care Equipment & Supplies Stocks to Buy Now - Investorplace.com
06/21/16 07:54 AMPre-Market Investor's Alert: GlobeImmune Inc(NASDAQ:GBIM), Cerus Corporation(NASDAQ:CERS) - iStreetWire
06/20/16 03:08 PMCerus snags up to $180M from BARDA for blood pathogen reduction system
06/20/16 03:08 PMCerus inks 5-year contract with BARDA potentially worth $180.5M to develop INTERECEPT for pathogen reduction of red blood cell components
06/20/16 12:03 PMCerus Corporation is Surging Today. Here's Why. - Shares of the blood-transfusion specialist are on the move after news broke that it has won a lucrative government contract.
06/20/16 09:31 AMCerus Corporation (CERS) Bursts Higher on BARDA Funding
06/20/16 09:31 AMCerus Announces Agreement with BARDA for Potential Funding of up to Approximately $180 Million to Advance Its INTERCEPT Red Blood Cell Program
06/20/16 09:31 AMCerus : CERS Gets BARDA Funding, EPZM Abuzz, ZSAN Awaits Data In Q1 2017
06/20/16 09:31 AMCerus, Terumo land $48m in BARDA grants for anti-Zika push
06/20/16 09:31 AMCerus (CERS) Inks Agreement with BARDA for RBC Component Pathogen Reduction Program
06/20/16 07:26 AMCerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : June 20, 2016 -
06/19/16 03:01 PMCerus Announces Agreement with BARDA for Potential Funding of up to Approximately $180 Million to Advance Its ... - Business Wire (press release)
06/14/16 03:04 PMBuy Sell or Hold? - Praxair Inc. (NYSE:PX), Cerus Corporation (NASDAQ:CERS) - Beacon Chronicle
06/09/16 03:34 PMCERUS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/09/16 09:58 AMCerus Corporation (NasdaqGM:CERS) Fundamental Star Rating Report - CML News
06/09/16 09:11 AMThe Probable Reason Behind Cerus Corp's 11.2% Drop in May -
06/08/16 03:43 PMEarnings Trends of the Stocks: Cerus Corporation (NASDAQ:CERS), ING Groep N.V. (NYSE:ING) - Beacon Chronicle
06/08/16 01:15 PMETF’s with exposure to Cerus Corp. : June 8, 2016 -
06/08/16 07:18 AMCerus Corp. breached its 50 day moving average in a Bullish Manner : CERS-US : June 8, 2016 -
06/07/16 08:49 PMCerus Corporation (CERS) Jumps 5.05% on June 07 - Equities.com
06/06/16 08:35 PMCERUS CORPORATION (NASDAQ:CERS) Financial Condition Compared to S&P 500 - CML News
06/06/16 07:29 AMCerus Co. (CERS) Rating Reiterated by FBR & Co. - Let Me Know About This
06/03/16 03:14 PMCerus Corporation (CERS) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News
06/01/16 11:43 AMWill You Buy These Stocks? - Hovnanian Enterprises Inc. (HOV), Cerus Corporation (CERS) - Beacon Chronicle - Beacon ChronicleWill You Buy These Stocks? - Hovnanian Enterprises Inc. (HOV), Cerus Corporation (CERS)Beacon ChronicleLast Trade: The Company closed its last session at $5.56 with the gain of 0.91%. The market capitalization of the company is $569.62 Million, with the average Volume of 1.23 Million. The stock currently has its 52-Week High range of $6.89 and 52-week ...and more »
05/31/16 12:48 PMWHO Raises Abstinence/Safe-Sex Period To 8 Weeks For Individuals Returning From Zika Areas -
05/31/16 08:37 AMAnalysts Predict 34% Gains Ahead For IBB - Three of IBB's underlying holdings with notable upside to their analyst target prices are Bellicum Pharmaceuticals Inc (Symbol: BLCM), Pacira Pharmaceuticals Inc. (Symbol: PCRX), and Cerus Corp. (Symbol: CERS). Although BLCM has traded at a recent price of ...
05/28/16 12:44 AMCerus Corporation (NASDAQ:CERS) Shorted Shares Increased 6.3% After Market Selling - HNN - Cerus Corporation (NASDAQ:CERS) Shorted Shares Increased 6.3% After Market SellingHNNThe stock of Cerus Corporation (NASDAQ:CERS) registered an increase of 6.3% in short interest. CERS's total short interest was 13.72 million shares in May as published by FINRA. Its up 6.3% from 12.91 million shares, reported previously. With 1.11 ...Notable Buzzers: Cerus Corporation (NASDAQ:CERS) , Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)Street UpdatesCerus Corporation (NASDAQ:CERS) Closes At $5.550Investor NewswireCerus Corporation (NASDAQ:CERS): Analysts Quick Take on EarningsNews TribuneNYSE Journal (press release) -Risers & Fallersall 6 news articles »
05/26/16 12:12 AMHow Many Cerus Corporation (NASDAQ:CERS)'s Analysts Are Bullish? - Wall Street Hints and News - How Many Cerus Corporation (NASDAQ:CERS)'s Analysts Are Bullish?Wall Street Hints and NewsOut of 5 analysts covering Cerus (NASDAQ:CERS), 5 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Cerus has been the topic of 3 analyst reports since August 11, 2015 according to StockzIntelligence Inc. Below is a list of Cerus ...Scorching Hot Biotech Stocks Tape: Cerus (CERS), Amgen (AMGN)Zergwatchall 2 news articles »
05/23/16 06:58 PMCerus Corporation (NASDAQ:CERS) Short Interest Decreased By 1.33% - Wall Street Hints and News - ZergwatchCerus Corporation (NASDAQ:CERS) Short Interest Decreased By 1.33%Wall Street Hints and NewsThe stock of Cerus Corporation (NASDAQ:CERS) registered a decrease of 1.33% in short interest. CERS's total short interest was 12.91 million shares in May as published by FINRA. Its down 1.33% from 13.08M shares, reported previously. With 1.00 million ...Stocks Movements to Focus: Cerus Corporation (NASDAQ:CERS) , Biodel Inc. (NASDAQ:BIOD)Street UpdatesTwo Biotechnology Names Are Hot: Cerus Corporation (CERS), Rock Creek Pharmaceuticals, Inc. (RCPI)ZergwatchCerus Corporation (NASDAQ:CERS) Earns Consensus Buy RatingiStreetWireThe Point Reviewall 7 news articles »
05/23/16 12:15 PMCerus : Health Canada Approves INTERCEPT Blood System for Plasma - Cerus Corporation (NASDAQ:CERS) today announced that Health Canada has approved the INTERCEPT Blood System for plasma. The INTERCEPT Blood System for plasma is intended to be used for the ex vivo preparation of pathogen-reduced, whole blood derived or ...
05/23/16 12:15 PMCanada OKs Cerus' INTERCEPT Blood System for plasma - Health Canada approves Cerus' (NASDAQ:CERS) INTERCEPT Blood System for the ex vivo preparation of pathogen-reduced whole blood-derived or apheresis plasma to reduce the risk of transfusion-transmitted infection. INTERCEPT enhances the safety of donated ...
About Cerus Corp.

Cerus Corp. logoCerus Corporation is a biomedical products company engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including HIV, West Nile, SARS, hepatitis B and C; bacteria and parasites, as well as potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company has commercial rights for its INTERCEPT Blood System for three blood components: platelets, plasma and red blood cells. The INTERCEPT Blood System for platelets or platelet system and the INTERCEPT Blood System for plasma or plasma system are being marketed and sold in a number of countries, including the United States, certain countries in Europe, The Commonwealth of Independent States (CIS) and the Middle East. The INTERCEPT Blood System for red blood cells is in development-stage.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: CERS
  • CUSIP: 15708510
Key Metrics:
  • Previous Close: $6.27
  • 50 Day Moving Average: $5.77
  • 200 Day Moving Average: $5.79
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $637.72M
  • Current Quarter EPS Consensus Estimate: $-0.65 EPS
Additional Links:
Cerus Corp. (NASDAQ:CERS) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha